RCKT - ROCKET PHARMACEUTICALS INC
This page shows which of the focused investors we track hold RCKT and how their positions changed, so you can see how much conviction the group has in the stock.
In Q1 2025 it was held by 2 managers with an aggregate reported value of $35.46M, which is 0.00% of the combined portfolio.
As of Q1 2025, 2 tracked institutional managers held RCKT (ROCKET PHARMACEUTICALS INC) with an aggregate reported value of $35.46M — 0.00% of the combined AlphaBaseline portfolio.
Get email alerts when a tracked manager trades RCKT — sign in or create a free account.
- Source
- Curated SEC 13F filings
- Period
- Q1 2025
- Ticker
- RCKT
13F data is delayed and excludes shorts/non-13F assets.
Holders
| 1 | Lee Ainslie - Maverick Capital | 0.62% | Add +0.0% | 5,199,218 | $34.68M |
| 2 | Torray Funds - Torray Funds | 0.12% | Reduce -3.9% | 117,301 | $782.4K |
Loading holder history for RCKT…